A Study of Breath Testing for Small Intestinal Bacterial Overgrowth

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT05976165
Status
Recruiting
Apply to this trial

Conditions

  • Gastroesophageal Reflux
  • Heartburn
  • Regurgitation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Breath Testing — OTHER
    Subjects drink a small carbohydrate solution, and then provide a breath sample every 15 minutes for one hour, and then every 30 minutes for the next two hours

Study Details

Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.

Key Dates

Start date
Nov 17, 2023
Status verified
Feb 2026
Primary completion
Jan 1, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Breath Test Evaluation for SIBO
    Subjects with symptoms of gastroesophageal reflux disease (GERD) treated with a short course of proton pump inhibitors (PPI) clinically will undergo breath testing evaluating for small intestinal bacterial overgrowth (SIBO).

Primary Outcome Measure

Incidence of SIBO after treatment with PPI [ Time Frame: After PPI therapy, approximately 8 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic FloridaJacksonvilleFlorida32224
Andree H Koop, MD
[email protected]
9049533970

Find similar trials in Jacksonville, FL

By research site
Mayo Clinic Florida· Jacksonville, FL

Related Studies